MEGAN CUMMINGS: Open Payments
NPI 1407191513 · OVERLAND PARK, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,284 in 165 payments from 20 companies in 2025. Trend: 2023 $378 · 2024 $1,842 · 2025 $3,284
Food & beverage: $3,019Education: $264
| Company | Payments | Amount |
|---|---|---|
| LEO Pharma Inc. | 19 | $416 |
| Galderma Laboratories, L.P. | 21 | $407 |
| ABBVIE INC. | 15 | $286 |
| Janssen Biotech, Inc. | 10 | $248 |
| UCB, Inc. | 10 | $233 |
| E.R. Squibb & Sons, L.L.C. | 17 | $214 |
| GENZYME CORPORATION | 9 | $184 |
| Novartis Pharmaceuticals Corporation | 9 | $179 |
| Almirall LLC | 10 | $179 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 6 | $167 |
Products named: NEMLUVIO, ADBRY, DUPIXENT, TREMFYA, Bimzelx, Sotyktu, SKYRIZI, TALTZ.
Industry payments across KS — which companies pay providers there.
